Dundee Company Portfolio Holding, TauRx Prescription drugs Ltd., Publicizes Transfer Towards Regulatory Submission Following Preliminary Knowledge From LUCIDITY Trial

TORONTO, Could 31, 2022 (GLOBE NEWSWIRE) — Dundee Company (TSX: DC.A) (the “Company” or “Dundee”) at present publicizes that TauRx Prescription drugs Ltd. (“TauRx”), a frontrunner in tau-based analysis in Alzheimer’s, unveiled preliminary information from the randomised portion of their extensively adopted Part 3 scientific trial, LUCIDITY (NCT03446001). Dundee holds 1,015,008 shares in TauRx. For a replica of TauRx’s official announcement, please go to:

https://ts-assets.ams3.cdn.digitaloceanspaces.com/mg/tx/pdfs/Lucidity-Knowledge-Announcement.31May2022.for-website.pdf

TauRx Announcement Highlights:

• LUCIDITY information counsel that individuals receiving hydromethylthionine mesylate (“HMTM”) decline at a charge considerably lower than is typical in Alzheimer’s based mostly on printed analysis.

• Security profile is beneficial and in line with earlier HMTM research.

• TauRx will now pursue regulatory submission and protection for HMTM.

TauRx stories their lead investigative oral drug, HMTM, was examined in 598 folks with Alzheimer’s. TauRx introduced individuals of the 12-month blinded part of the research have moved to an extra one-year open label part.

In accordance with TauRx’s announcement, Professor Claude Wischik, Govt Chairman and Co-Founding father of TauRx, commented: “The output signifies that individuals receiving HMTM decline at a charge considerably lower than is typical in Alzheimer’s based mostly on printed analysis. This was seen for each cognitive and practical endpoints throughout a broad vary of severity from delicate cognitive impairment (MCI) to reasonable Alzheimer’s. Importantly, the security profile is beneficial and in line with earlier research”.

TauRx advises their information evaluation is ongoing and shall be reported at a later date. In the meantime, TauRx shall be offering an replace on their progress on the 35^th International Convention of Alzheimer’s Illness on June 9^th, 2022.

ABOUT DUNDEE CORPORATION:

Dundee Company is a public Canadian unbiased holding firm, listed on the Toronto Inventory Alternate below the image “DC.A”. By way of its working subsidiaries, Dundee Company is an lively investor targeted on delivering long-term, sustainable worth as a trusted associate within the mining sector with greater than 30 years of expertise making accretive mining investments.

Story continues

FORWARD-LOOKING STATEMENTS:

This press launch could include forward-looking data throughout the that means of relevant securities laws, which displays Dundee Company’s present expectations concerning future occasions. Ahead-looking data is predicated on a lot of assumptions and is topic to a lot of dangers and uncertainties, lots of that are past Dundee Company’s management, which might trigger precise outcomes and occasions to vary materially from these which can be disclosed in or implied by such forward-looking data. Such dangers and uncertainties embody, however aren’t restricted to, the elements mentioned below “Danger Elements” within the Annual Info Type of Dundee Company and subsequent filings made with securities commissions in Canada. Dundee Company doesn’t undertake any obligation to replace such forward-looking data, whether or not because of new data, future occasions or in any other case, besides as expressly required by relevant regulation.

FOR FURTHER INFORMATION PLEASE CONTACT:

Investor and Media Relations
T: (416) 864-3584
E: ir@dundeecorporation.com